Scientific Information

Organising Institutions

International Foundation for Maternal Periconceptional and Peri- neonatal Medicine (FIMPP) founded by a group of highly professional and enthusiastic obstetricians and neonatologists, the worldwide known experts in the field that aim to revive the interest around maternal and neonatal care.
FIMPP is composed of Board of Directors, chaired by Prof. Gian Carlo Di Renzo from Italy and Board of Scientific Advisors, chaired by Prof. Umberto Simeoni from Switzerland.
The purpose of FIMPP is to foster education, research and advocacy in maternal, periconceptional and neonatal medicine and care worldwide. The Foundation aims to promote and disseminate the study, research and knowledge on the aspects of maternal, periconceptional and neonatal medicine, in order to attain, by appropriate means, a higher level of physical and mental health for women,
mothers, and their children.
Collaboration between various disciplines interested in maternal, perception, and perinatal care as well as friendship between individuals from different world countries will lead to improving the quality and provision of care in the world.

Congress Committees

Congress Presidents
 

Scientific Committee

Scientific Committee
 

Scientific Programme

09:00-09:05

WELCOME FROM CONGRESS PRESIDENTS

Yves Ville, France / Francesco Raimondi, Italy / Efraim Bilavsky, Israel

09:05-11:10

SESSION 1 – Prenatal Management of maternal primary infections, State of the science and gaps

Moderators: Yves VILLE - Jacob AMIR

09:05-09:25

Maternal serologies made (more or less) easy

09:25-09:45

Secondary Prevention following maternal primary infection

09:45-10:00

Non-invasive prediction of fetal infection by ultrasound

10:00-10:15

Non-invasive prediction of fetal infection in maternal blood

10:15-10:30

Chorionic villus sampling or amniocentesis for prenatal diagnosis ?

10:30-10:50

Negative amniocentesis with or without maternal anti-viral treatment – what are the clinical implications?

10:50-11:00

Discussion

11:00-11:15

ECCI & ESCV Prenatal Recommendations

11:15-11:35

COFFEE BREAK

11:35-13:00

SESSION 2 –Oral communications

Moderators: Daniele Lilleri - Marianne Leruez

13:00-14:00

LUNCH/POSTER VIEWING

14:00-15:45

SESSION 3 – Interactive cases

Moderators: Tiziana Lazzaroto - Anna Gonce

14:00-14:45

Tricky cases

14:45-15:45

Your cases!

15:45-16:15

COFFEE BREAK

16:15-17:30

SESSION 3 - Long term sequelae and impact of Newborn Universal screening

Moderators: Ana Alarcon-Francesco

16:15-16:35

Optimizing Outcomes in Children with Congenital CMV through Early Hearing Intervention

16:35-17:15

Debate: Universal Neonatal screening

17:15-17:35

Impact of behavioral disorders in management of hearing loss in congenital CMV

17:35-18:00

Oral Communications

18:00-18:15

Discussion

09:00-11:15

SESSION 4 – Fetal infection - Prognosis

09:00-09:20

The prognosis of an infected fetus: Overview

09:20-09:40

Fetal prognosis following failure of secondary prevention

09:40-10:00

Intrauterine treatment, pharmacological update

10:00-10:20

Prenatal and Postnatal MRI in infected fetuses and neonates

10:20-10:50

Cases discussion

10:50-11:20

Oral Communications

11:20-11:50

COFFEE BREAK

11:50-12:15

Postnatal recommendation of ECCI-ESC V

12:20-13:30

LUNCH AND POSTER VIEWING

13:30-16:05

SESSION 5 - Hearing and vestibular sequela in children with cCMV

13:30-13:50

Long term vestibular function in cCMV

13:50-14:10

Long-term Hearing Instability in Children with Congenital CMV

14:10-14:30

Profound hearing loss in children with cCMV infection: What is the impact in daily life?

14:30-15:05

Oral Communication

15:05-15:30

COFFEE BREAK

15:30-16:05

Oral Communication

16:05-16:35

CLOSING REMARKS

Yves Ville, Francesco Raimondi, Efraim Bilavsky